Loading...

TVTX TRAVERE THERAPEUTICS INC Earnings Reports 8-K Filing

TRVR

TVTX

TRAVERE THERAPEUTICS INC

(TVTX)

2025 8-K

Show Summary

Summary

Regulatory Compliance

Financial Statements

Financial Statements

New Product Launches

Earnings Update

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Q3 Earnings Report

Merger of Equals

Financial Results

Financial Performance

Quantitative Data

Quantitative Data

Other Special Situation

Resignation of CFO

Merger of Equals

Positive Study Results for ...

Merger of Equals

Quantitative Data

Filing with Quantitative Data

Financial Update

Quantitative Data

Filing with Quantitative Data

Financial Performance

Public Offering

Quantitative Data

Financial Results

Other Special Situation

External Links:

On May 1, 2025, Travere Therapeutics, Inc. corrected an item number in their previous 8-K filing to ensure proper tagging, with no changes to the disclosed financial results for the quarter ended March 31, 2025.

AI Assistant

TRAVERE THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.